NYSE:FMS

Fresenius Medical Care AG & Co. KGaA - FMS Stock Forecast, Price & News

$14.14

-0.71 (-4.78%)

(As of 10/5/2022 12:00 AM ET)

Add

Compare

Today's Range: $13.95
▼
$14.23
50-Day Range: $13.76
▼
$19.32
52-Week Range: $13.69
▼
$36.08

Volume: 1.22 million shs
Average Volume: 700,274 shs
Market Capitalization: $8.29 billion

P/E Ratio: 9.01
Dividend Yield: 3.30%
Price Target: $45.83

Fresenius Medical Care AG & Co. KGaA MarketRank™ Forecast

Analyst Rating: Hold
2.18 Rating Score
Upside/Downside: 224.1% Upside
$45.83 Price Target
Short Interest: Healthy
0.07% of Shares Sold Short
Dividend Strength: Moderate
Based on Four Factors
Sustainability: N/A
News Sentiment: 1.55
Based on 3 Articles This Week
Insider Trading: N/A
Proj. Earnings Growth: 13.41%
From $1.64 to $1.86 Per Share

Overall MarketRank^™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

3.02 out of 5 stars

Medical Sector

20th out of 1,072 stocks

Miscellaneous Health & Allied Services, Not Elsewhere Classified Industry

1st out of 11 stocks

3.1

Analyst's Opinion

Consensus Rating
Fresenius Medical Care AG & Co. KGaA has received a consensus rating of Hold. The company's average rating score is 2.18, and is based on 3 buy ratings, 7 hold ratings, and 1 sell rating.
Price Target Upside/Downside
According to analysts' consensus price target of $45.83, Fresenius Medical Care AG & Co. KGaA has a forecasted upside of 224.1% from its current price of $14.14.
Amount of Analyst Coverage
Fresenius Medical Care AG & Co. KGaA has only been the subject of 2 research reports in the past 90 days.

3.0

Short Interest

Percentage of Shares Shorted
0.07% of the outstanding shares of Fresenius Medical Care AG & Co. KGaA have been sold short.
Short Interest Ratio / Days to Cover
Fresenius Medical Care AG & Co. KGaA has a short interest ratio ("days to cover") of 0.4, which is generally considered an acceptable ratio of short interest to trading volume.
Change versus previous month
Short interest in Fresenius Medical Care AG & Co. KGaA has recently increased by 52.06%, indicating that investor sentiment is decreasing significantly.

2.5

Dividend Strength

Dividend Yield
Fresenius Medical Care AG & Co. KGaA pays a meaningful dividend of 3.30%, higher than the bottom 25% of all stocks that pay dividends.
Dividend Growth
Fresenius Medical Care AG & Co. KGaA does not have a long track record of dividend growth.
Dividend Coverage
The dividend payout ratio of Fresenius Medical Care AG & Co. KGaA is 31.21%. This payout ratio is at a healthy, sustainable level, below 75%.
Dividend Sustainability
Based on earnings estimates, Fresenius Medical Care AG & Co. KGaA will have a dividend payout ratio of 26.34% next year. This indicates that Fresenius Medical Care AG & Co. KGaA will be able to sustain or increase its dividend.

N/A

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
There is no current Upright™ data available for FMS.

3.6

News and Social Media Coverage

News Sentiment
Fresenius Medical Care AG & Co. KGaA has a news sentiment score of 1.55. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.81 average news sentiment score of Medical companies.
News Coverage This Week
MarketBeat has tracked 3 news articles for Fresenius Medical Care AG & Co. KGaA this week, compared to 1 article on an average week.
Search Interest
3 people have searched for FMS on MarketBeat in the last 30 days. This is an increase of 50% compared to the previous 30 days.
MarketBeat Follows
Only 11 people have added Fresenius Medical Care AG & Co. KGaA to their MarketBeat watchlist in the last 30 days. This is a decrease of -8% compared to the previous 30 days.

0.0

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Fresenius Medical Care AG & Co. KGaA insiders have not sold or bought any company stock.
Percentage Held by Institutions
Only 5.59% of the stock of Fresenius Medical Care AG & Co. KGaA is held by institutions.

4.4

Earnings and Valuation

Earnings Growth
Earnings for Fresenius Medical Care AG & Co. KGaA are expected to grow by 13.41% in the coming year, from $1.64 to $1.86 per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of Fresenius Medical Care AG & Co. KGaA is 9.01, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 123.07.
Price to Earnings Ratio vs. Sector
The P/E ratio of Fresenius Medical Care AG & Co. KGaA is 9.01, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 125.93.
Price to Earnings Growth Ratio
Fresenius Medical Care AG & Co. KGaA has a PEG Ratio of 0.71. PEG Ratios below 1 indicate that a company could be undervalued.
Price to Book Value per Share Ratio
Fresenius Medical Care AG & Co. KGaA has a P/B Ratio of 0.50. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

About Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) Stock

Fresenius Medical Care AG & Co. KGaA provides dialysis care and related dialysis care services in Germany, North America, and internationally. It offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure. The company also develops, manufactures, and distributes dialysis products, including polysulfone dialyzers, hemodialysis machines, peritoneal dialysis cyclers, peritoneal dialysis solutions, hemodialysis concentrates, solutions and granulates, bloodlines, renal pharmaceuticals, and systems for water treatment; and non-dialysis products, such as acute cardiopulmonary and apheresis products. In addition, it develops, acquires, and in-licenses renal pharmaceuticals; offers renal medications and supplies to patients at homes or to dialysis clinics; and provides vascular, cardiovascular, endovascular specialty, vascular care ambulatory surgery center, and physician nephrology and cardiology services. The company sells its products to dialysis clinics, hospitals, and specialized treatment clinics directly, as well as through local sales forces, independent distributors, dealers, and sales agents. As of February 23, 2022, it operated 4,171 outpatient dialysis clinics in approximately 150 countries. Fresenius Medical Care AG & Co. KGaA was incorporated in 1996 and is headquartered in Bad Homburg, Germany.

Receive FMS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Fresenius Medical Care AG & Co. KGaA and its competitors with MarketBeat's FREE daily newsletter.

FMS Stock News Headlines

October 4, 2022 | americanbankingnews.com

Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) Coverage Initiated at StockNews.com

September 27, 2022 | americanbankingnews.com

Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) Research Coverage Started at StockNews.com

September 23, 2022 | seekingalpha.com

FMS Fresenius Medical Care AG & Co. KGaA

September 15, 2022 | finance.yahoo.com

Fresenius Medical Care AG & Co. KGaA (FMS)

September 12, 2022 | finance.yahoo.com

Fresenius Kidney Care Celebrates Nephrology Nurses Week with The CARE Award

August 2, 2022 | finance.yahoo.com

CytoSorb® Becomes a Featured Blood Purification Therapy on Fresenius Medical Care Critical Care Platforms

August 2, 2022 | nasdaq.com

Fresenius Medical's (FMS) Q2 Earnings Miss, Revenues Top

July 28, 2022 | finance.yahoo.com

Fresenius Medical Care AG & Co. KGaA: After Tough Q2, Fresenius' Outlook Cut for 2022, Pulled for 2025; Shares Cheap Even After FVE Cut

July 27, 2022 | finance.yahoo.com

Fresenius Medical Care North America Introduces First Single-Use Integrated Bloodline to Support Fluid Management in Dialysis

July 4, 2022 | morningstar.com

Fresenius Medical Care AG & Co. KGaA ADR - Stock Valuation FMS

June 21, 2022 | finance.yahoo.com

Fresenius Medical Care AG & Co. KGaA: Supreme Court Ruling Raises Uncertainty for DaVita and Fresenius

June 21, 2022 | morningstar.com

Fresenius Medical Care AG & Co. KGaA ADR - Stock Analysis

June 18, 2022 | morningstar.com

Fresenius Medical Care AG & Co. KGaA ADR - Stock Financials FMS

May 7, 2022 | finance.yahoo.com

Fresenius Medical Care AG & Co. KGaA: Despite Challenges, Fresenius Looking to Grow Profits After a Weak 2021

May 4, 2022 | finance.yahoo.com

Fresenius Medical Care AG & Co. KGaA: After Tough Q1, Fresenius Medical Care Maintains Outlook for 2022; Shares Undervalued

May 4, 2022 | seekingalpha.com

Fresenius Medical Care AG & Co. (FMS) CEO Rice Powell on Q1 2022 Results - Earnings Call Transcript

May 4, 2022 | nasdaq.com

Fresenius Medical Care Q1 Profit Down, Revenues Rise; Confirms FY22 Outlook - Quick Facts

April 20, 2022 | stocknews.com

Tired of the Market's Volatile Swings? Then Add These 3 Dividend Stocks to Your Portfolio

April 14, 2022 | finance.yahoo.com

Fresenius Medical (FMS) Launches Campaign to Boost Kidney Care

April 5, 2022 | finance.yahoo.com

Fresenius Medical Care Appoints Dr. Amaka Eneanya as Head of Strategy and Operations for Company's Global Medical Office

March 29, 2022 | finance.yahoo.com

Focus Graphite Inc. is pleased to participate in the VirtualInvestorConferences.com Live Webcast March 30th

March 23, 2022 | finance.yahoo.com

Fresenius Medical's (FMS) Merger Deal to Improve Kidney Care

March 21, 2022 | finance.yahoo.com

Fresenius Medical Care's US Unit Announces $2.4B Three-Way Merger Agreement

March 10, 2022 | finance.yahoo.com

How Fresenius Medical Care’s Superhero Is Helping Bridge the Knowledge Gap to Better Kidney Health

March 1, 2022 | finance.yahoo.com

Here’s Why Fresenius Medical Care (FMS) Landed in Artisan Partners’ Detractor List

See More Headlines

30 days | 90 days | 365 days | Advanced Chart

Receive FMS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Fresenius Medical Care AG & Co. KGaA and its competitors with MarketBeat's FREE daily newsletter.

FMS Company Calendar

Last Earnings: 7/28/2022
Today: 10/05/2022
Next Earnings (Estimated): 11/01/2022
Fiscal Year End: 12/31/2022

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NYSE
Industry: Miscellaneous health & allied services, not elsewhere classified
Sub-Industry: N/A
Sector: Medical
Current Symbol: NYSE:FMS
CUSIP: N/A
CIK: 1333141
Web: www.freseniusmedicalcare.com
Phone: (496) 172-6090
Fax: 49-6172-609-2301
Employees: 122,909
Year Founded: 1912

Price Target and Rating

Average Stock Price Forecast: $45.83
High Stock Price Forecast: $72.00
Low Stock Price Forecast: $23.00
Forecasted Upside/Downside: +224.1%
Consensus Rating: Hold
Rating Score (0-4): 2.18
Research Coverage: 11 Analysts

Profitability

EPS (Most Recent Fiscal Year): $1.57
Trailing P/E Ratio: 9.01
Forward P/E Ratio: 8.62
P/E Growth: 0.71
Net Income: $1.15 billion
Net Margins: 4.42%
Pretax Margin: 7.48%
Return on Equity: 6.70%
Return on Assets: 2.77%

Debt

Debt-to-Equity Ratio: 0.47
Current Ratio: 1.18
Quick Ratio: 0.85

Sales & Book Value

Annual Sales: $20.85 billion
Price / Sales: 0.40
Cash Flow: $5.30 per share
Price / Cash Flow: 2.67
Book Value: $28.22 per share
Price / Book: 0.50

Miscellaneous

Outstanding Shares: 586,055,000
Free Float: N/A
Market Cap: $8.29 billion
Optionable: Optionable
Beta: 1.06

Social Links

Key Executives

Mr. Robert Maurice Powell Jr. (Age 67)
Chairman of the Management Board & CEO of Fresenius Medical Care Management AG
Comp: $3.39M

Ms. Helen Giza (Age 54)
Deputy CEO, Chief Transformation Officer, CFO & Member of Mgmt Board of Fresenius Med. Care Mgmt AG
Comp: $1.75M

Dr. Franklin W. Maddux F.A.C.P. (Age 65)
Global Chief Medical Officer & Member of Management Board of Fresenius Medical Care Management AG
Comp: $1.56M

Mr. William J. Valle (Age 62)
Management Board Member for Care Delivery of Fresenius Medical Care Management AG
Comp: $3.86M

Dr. Katarzyna Mazur-Hofsab Ph.D. (Age 59)
Management Board Member for Care Enablement of Fresenius Medical Care Management AG
Comp: $4.3M

Mr. Roberto Fuste (Age 70)
Exec. Advisor for Regional Strategy

Dr. Nwamaka Eneanya M.D.
Head of Strategy & Operations

Dr. Dominik Heger
Exec. VP and Head of Investor Relations, Strategic Devel. & Communications

Mr. Borries Von Muller (Age 61)
Sr. VP of Global HR Employee Communications

Mr. Joachim Weith
Sr. VP of Corp. Communications & Gov.al Affairs

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions

FMS Stock - Frequently Asked Questions

Should I buy or sell Fresenius Medical Care AG & Co. KGaA stock right now?: 11 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Fresenius Medical Care AG & Co. KGaA in the last twelve months. There are currently 1 sell rating, 7 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" FMS shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in FMS, but not buy additional shares or sell existing shares.
View FMS analyst ratings or view top-rated stocks.
What is Fresenius Medical Care AG & Co. KGaA's stock price forecast for 2022?: 11 equities research analysts have issued twelve-month price objectives for Fresenius Medical Care AG & Co. KGaA's shares. Their FMS share price forecasts range from $23.00 to $72.00. On average, they anticipate the company's share price to reach $45.83 in the next twelve months. This suggests a possible upside of 224.4% from the stock's current price.
View analysts price targets for FMS or view top-rated stocks among Wall Street analysts.
How have FMS shares performed in 2022?: Fresenius Medical Care AG & Co. KGaA's stock was trading at $32.46 at the beginning of the year. Since then, FMS stock has decreased by 56.5% and is now trading at $14.13.
View the best growth stocks for 2022 here.
Are investors shorting Fresenius Medical Care AG & Co. KGaA?: Fresenius Medical Care AG & Co. KGaA saw a increase in short interest during the month of September. As of September 15th, there was short interest totaling 398,400 shares, an increase of 52.1% from the August 31st total of 262,000 shares. Based on an average daily trading volume, of 935,600 shares, the days-to-cover ratio is presently 0.4 days.
View Fresenius Medical Care AG & Co. KGaA's Short Interest.
When is Fresenius Medical Care AG & Co. KGaA's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Tuesday, November 1st 2022.
View our FMS earnings forecast.
How were Fresenius Medical Care AG & Co. KGaA's earnings last quarter?: Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) released its quarterly earnings results on Thursday, July, 28th. The company reported $0.41 earnings per share for the quarter, missing analysts' consensus estimates of $0.45 by $0.04. The firm earned $5.07 billion during the quarter, compared to analysts' expectations of $4.80 billion. Fresenius Medical Care AG & Co. KGaA had a trailing twelve-month return on equity of 6.70% and a net margin of 4.42%.
How often does Fresenius Medical Care AG & Co. KGaA pay dividends? What is the dividend yield for Fresenius Medical Care AG & Co. KGaA?: Fresenius Medical Care AG & Co. KGaA announced an annual dividend on Friday, April 29th. Stockholders of record on Monday, May 16th will be given a dividend of $0.7093 per share on Friday, May 27th. This represents a yield of 3.4%. The ex-dividend date of this dividend is Friday, May 13th.
Read our dividend analysis for FMS.
Is Fresenius Medical Care AG & Co. KGaA a good dividend stock?: Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) pays an annual dividend of $0.49 per share and currently has a dividend yield of 3.46%. The dividend payout ratio is 31.21%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, FMS will have a dividend payout ratio of 26.34% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for FMS.

What other stocks do shareholders of Fresenius Medical Care AG & Co. KGaA own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Fresenius Medical Care AG & Co. KGaA investors own include Energy Transfer (ET), Petra Diamonds (PDL), AT&T (T), Pfizer (PFE), AbbVie (ABBV), Gilead Sciences (GILD), Merck & Co., Inc. (MRK), Abbott Laboratories (ABT), Chevron (CVX) and Ford Motor (F).
What is Fresenius Medical Care AG & Co. KGaA's stock symbol?: Fresenius Medical Care AG & Co. KGaA trades on the New York Stock Exchange (NYSE) under the ticker symbol "FMS."
Who are Fresenius Medical Care AG & Co. KGaA's major shareholders?: Fresenius Medical Care AG & Co. KGaA's stock is owned by a variety of retail and institutional investors. Top institutional investors include Cacti Asset Management LLC (0.01%).
How do I buy shares of Fresenius Medical Care AG & Co. KGaA?: Shares of FMS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is Fresenius Medical Care AG & Co. KGaA's stock price today?: One share of FMS stock can currently be purchased for approximately $14.13.
How much money does Fresenius Medical Care AG & Co. KGaA make?: Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) has a market capitalization of $8.28 billion and generates $20.85 billion in revenue each year. The company earns $1.15 billion in net income (profit) each year or $1.57 on an earnings per share basis.
How many employees does Fresenius Medical Care AG & Co. KGaA have?: The company employs 122,909 workers across the globe.
Does Fresenius Medical Care AG & Co. KGaA have any subsidiaries?: The following companies are subsidiares of Fresenius Medical Care AG & Co. KGaA: NxStage Medical.
Read More
How can I contact Fresenius Medical Care AG & Co. KGaA?: Fresenius Medical Care AG & Co. KGaA's mailing address is ELSE-KROENER STRASSE 1, BAD HOMBURG 2M, 61352. The official website for the company is www.freseniusmedicalcare.com. The company can be reached via phone at (496) 172-6090, via email at ir@fmc-ag.com, or via fax at 49-6172-609-2301.

This page (NYSE:FMS) was last updated on 10/6/2022 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Fresenius Medical Care AG & Co. KGaA - FMS Stock Forecast, Price & News

Fresenius Medical Care AG & Co. KGaA MarketRank™ Forecast

Overall MarketRank™

Analyst's Opinion

Short Interest

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

Change versus previous month

Dividend Strength

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score

News and Social Media Coverage

News Sentiment

News Coverage This Week

Search Interest

MarketBeat Follows